Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Flow-mediated dilation of brachial artery predicts renal dysfunction in sickle cell disease

Publish date:: February 7, 2020

Key clinical point: Sonographic flow-mediated dilation (FMD) of the brachial artery may predict renal dysfunction in patients with sickle cell disease (SCD).

Major finding: Flow-mediated dilation (FMD) was negatively correlated with serum level of cystatin C (P = .013).

Study details: A cross-sectional comparative study involving 44 patients with homozygous SCD and 33 age- and sex-matched controls.

Disclosures: The study was funded by the Obafemi Awolowo University Teaching Hospital. The investigators reported no conflicts of interest.

Citation:

Ayoola et al. Kidney360. 2020 Jan 30. doi: 10.34067/KID.0000142019.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Anemia

Emotions, worse attention linked to pain-related health care use SCD,

Oxidatative stress-related genetic variant tied to stroke risk in sickle cell patients,

Genetic variants may predict stroke in some adult SCD populations,

Severe COVID-19 may lower hemoglobin levels,

Low plasma sodium levels can predict complications in acute painful episodes of SCD,